Key Takeaways The number of people taking GLP-1 drugs to lose weight more than tripled in recent yearsThe percentage of ...

Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

In studies, many people lost weight while using Ozempic to treat type 2 diabetes or to ... Because of this, both drugs are expected to work in the same way for weight loss. They’re also expected ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

And it has been largely considered to be the next generation in obesity and diabetes drugs. In a small Phase II trial in China, the drug triggered an average 15.1% weight loss over 12 weeks.

Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...

Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...

Researchers discovered that individuals using these medications experienced ... semaglutide specifically for weight loss purposes, carefully excluding those with diabetes or who had been ...

New research suggests that drugs like Ozempic may provide more health benefits than previously thought. These medications, ...